A AddLife AB
A
Avatud
142.4 -6.13
Ülevaade
Aktsiahinna muutus
24h
Min
142.4
Max
146.5
Sissetulek | 179M 260M |
|---|---|
Müük | 304M 2.7B |
P/E Sektori keskmine | 31.438 86.001 |
Aktsiakasum | 1.15 |
Dividenditootlus | 0.99 |
Kasumimarginaal | 9.513 |
Töötajad | 2,319 |
EBITDA | 238M 602M |
Dividenditootlus Sektori keskmine | 0.99% 2.73% |
|---|
Turukapital | 999M 18B |
|---|---|
Eelmine avamishind | 148.53 |
Eelmine sulgemishind | 142.4 |
AddLife AB Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
AddLife AB Prognoos
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
